KZA 0.00% 35.0¢ kazia therapeutics limited

Yes you're absolutely right. After some more discussion and leg...

  1. 5,553 Posts.
    lightbulb Created with Sketch. 1239
    Yes you're absolutely right. After some more discussion and leg work I am more inclined to move my initial opinion and position of genentech being embarrassed they missed out to more genetech is supportive of the drug going forward. Again Genentech do not have any brain cancer drugs at all in their pipeline at all...........at this stage! Why do I say at this stage because they are starting new trial just this year on their old drug GDC-0068 after 11 trials had gone nowhere, which could signal a a new look at these inhibitors for breast mets. Considering GDC-0084 got the nod for breast mets in the CNS trial with Alliance along with other mets, it not to hard to see how this would encourage them and prick their interest in the progress of GDC-0084
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
0.000(0.00%)
Mkt cap ! $21.75M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 9669 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 2429 1
View Market Depth
Last update - 10.26am 22/08/2019 (20 minute delay) ?
KZA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.